|ITEM METADATA RECORD
|Title: ||Exemestane (Aromasin) is active and well tolerated as first-line hormonal therapy (HT) of metastatic breast cancer (MBC) patients (pts): results of a randomized phase II trial|
|Authors: ||Paridaens, Robert ×|
Van Hoorebeeck, I.
Piccart, M. #
|Issue Date: ||2000 |
|Host Document: ||PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY vol:19 pages:83a|
|Publication status: ||published|
|KU Leuven publication type: ||IC|
|Appears in Collections:||Laboratory of Experimental Oncology |
× corresponding author|
# (joint) last author|
|Files in This Item:
There are no files associated with this item.
Request a copy
All items in Lirias are protected by copyright, with all rights reserved.